Cargando…
Gut microbiome-targeted therapies in liver cirrhosis: a protocol for systematic review and meta-analysis
BACKGROUND: Microbiome-targeted therapies (MTTs), including probiotics, prebiotics, synbiotics, and fecal microbiota transplantation (FMT), have been proposed as a potential treatment for cirrhosis via modulation of gut microbiome, while the impact of gut microflora alteration on liver function in c...
Autores principales: | Jiang, Honglin, Peng, Yan, Zhang, Wei, Chen, Yue, Jiang, Qingwu, Zhou, Yibiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429623/ https://www.ncbi.nlm.nih.gov/pubmed/36042459 http://dx.doi.org/10.1186/s13643-022-02059-3 |
Ejemplares similares
-
Alterations of gut microbiome and effects of probiotic therapy in patients with liver cirrhosis: A systematic review and meta-analysis
por: Huang, Long, et al.
Publicado: (2022) -
The Role of the Gut Microbiome in Liver Cirrhosis Treatment
por: Lee, Na Young, et al.
Publicado: (2020) -
Use of contact tracing, isolation, and mass testing to control transmission of covid-19 in China
por: Zhou, Yibiao, et al.
Publicado: (2021) -
Protocol for correlation analysis of the murine gut microbiome and meta-metabolome using 16S rDNA sequencing and UPLC-MS
por: Li, Xiaoqing, et al.
Publicado: (2022) -
Serum 25-hydroxyvitamin D levels and mortality risk in patients with liver cirrhosis: a protocol for a systematic review and meta-analysis of observational studies
por: Völker, Désirée, et al.
Publicado: (2019)